SCHEMBL6151956

SCHEMBL6151956

CC=NCCOCc1ccccc1CCC1=C(C(=O)O)C(C)(c2c(Cl)cccc2Cl)C(C(=O)O)=C(CC(=O)OC)N1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6152550 0.85 TDP1 (0.31)
SCHEMBL6152317 0.84 KDM4E (0.34)
SCHEMBL6152588 0.80 P2RX7 (0.32)
SCHEMBL6152925 0.80 L3MBTL1 (0.31)
SCHEMBL6152831 0.78 HRH1 (0.35)
SCHEMBL7240668 0.74 HRH1 (0.34)
SCHEMBL7252522 0.73 SLC16A3 (0.34)
SCHEMBL6151955 0.72 TBXA2R (0.37)
SCHEMBL8535870 0.71 KMT2A (0.35)
SCHEMBL6153099 0.67 CCR3 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1307449-B1 1,4-DIHYDROPYRIDINES AS BRADYKININ ANTAGONISTS PFIZER PHARMA (JP) 2005-12-07 EP disclosed
US-6653313-B2 For treatment and prevention of inflammation, asthma, allergic rhinitis, pain and other disorders WARNER-LAMBERT COMPANY LLC 2003-11-25 US disclosed